Actively Recruiting
Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine- SIGHT 2: A Pragmatic Randomized Trial
Led by University of Michigan · Updated on 2025-12-15
900
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
U
University of Michigan
Lead Sponsor
C
Centers for Disease Control and Prevention
Collaborating Sponsor
AI-Summary
What this Trial Is About
To compare eye disease detection rates at a Federally Qualified Health Center between a technology-enhanced protocol and standard optometric clinical examination for three of the leading causes of blindness: glaucoma, diabetic retinopathy, and visually significant cataract.
CONDITIONS
Brief Title
Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2
Who Can Participate
Eligibility Criteria
You may qualify if you...
• Speak English, Spanish, Arabic, Chinese, French, Hindi, Finnish, Albanian, Russian or Tagalog
You will not qualify if you...
- significant eye pain
- sudden decrease in vision within one week
- binocular diplopia
- cognitive impairment
- pregnancy
- previously declined participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hamilton Optometry Clinic
Flint, Michigan, United States, 48505.
Actively Recruiting
Research Team
S
Suzanne Winter, MS
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Similar Trials
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here